STAR Pharmaceutical Limited announced earnings results for the third quarter ended September 30, 2018. For the third quarter, the company announced sales was CNY 51.458 million compared to CNY 20.061 million a year ago. Operating loss was CNY 482,000 compared to operating Income of CNY 3.338 million a year ago. Net loss was CNY 267,000 compared to net income of CNY 2.552 million a year ago. Basic loss per share was CNY 0.0058 compared to basic earnings per share of CNY 0.0548 a year ago. For the nine months, sales was CNY 156.064 million compared to CNY 57.522 million a year ago. Operating income was CNY 7.874 million compared to CNY 9.928 million a year ago. Net income was CNY 9.728 million compared to CNY 7.792 million a year ago. Basic earnings per share was CNY 0.2094 compared to CNY 0.1672 a year ago.